| Standard not met | Reason | Action being taken by the Pharmacy | By when | Notification By Pharmacy Improvements Made |
|---|---|---|---|---|
| 1.1 | The pharmacy does not always effectively identify and manages risks before introducing a new service or making a change to an existing service or process. For example, it has made changes to its weight loss services without having assessed the risks involved. This means prescribing may not always be safe and people might receive medicines that are not appropriate. |
New risk assessment process is being implemented - moving towards overall centralised risk assessment. This will change from individual condition-based risk assessments. Capturing all pharmacy areas, including prescribing. This will capture proposed changes to any service or activity prior to launch, and links out to any relevant documents pertinent to that area. |
27/06/2025 | 01/07/2025 |
| 1.1 | The pharmacy provides additional treatments to help people manage side effects when they are supplied with weight loss medicines. But it does not conduct a thorough consultation to assess whether the medicine is safe and appropriate for the person concerned. |
Implementing a subsequent consultation depending upon the side effect being presented, ensuring safety netting for any red flag symptoms and that any prescribed treatment is appropriate. Lifestyle advice will also be offered in conjunction or indeed in place of any pharmaceutical treatment. |
27/06/2025 | 01/07/2025 |
| 1.1 | The pharmacy prescribes weight loss medicines in titration bundles. But it is unable to show that there are sufficient controls in place to make sure this option is suitable for the people it supplies. |
Bundle supply will be captured as part of centralised risk assessment. Additionally catch up with tech team has been arranged to look at implementation of automated phone call to patients who have had multiple weight loss pens prescribed. This will further build on two-way dialogue with patients prescribed weight loss bundles. This will be in conjunction with emails sent out at intervals informing patients of how they can contact a prescriber if they have concerns and how to manage potential side effects. |
27/06/2025 | 01/07/2025 |
| 1.1 | The pharmacy sometimes accepts evidence of previously dispensed medicines to prescribe medicines for long term conditions, such as asthma. This is not a reliable way to verify people’s healthcare condition when prescribing medicines remotely. |
Risk Assessment for long term conditions such as asthma has updated to include that if NHS Summary Care Record is not available, then a photo of the repeat medication slip or a screen short from the EMIS Patient Access or NHS app can be considered but not a picture of a dispensing label. |
27/06/2025 | 01/07/2025 |
Pharmacy inspections
Inspection reports and learning from inspections